Table 2.

Baseline characteristics of the SPRING trial participants based on survival status at follow-up (n = 431)

Characteristics Survived (n = 407)Died (n = 24)P value 
Age at enrollment, median (IQR) 7.7 (6.0-10.1) 7.5 (6.3-9.0) .778 
Female 211 (51.8) 13 (54.2) .825 
Total hemoglobin (g/dL), median (IQR) 7.3 (6.7-8.1) 7.2 (6.4-7.2) .547 
White blood cell count (103/mm3), median (IQR) 13.5 (11.2-16.9) 14.1 (12.5-17.3) .580 
Transcranial Doppler velocity at screening (cm/s), median (IQR) 200.0 (130.0-206.0) 203.5 (146.3-219.0) .113 
Height (cm) 118.5 (11.8) 115.1 (10.9) .168 
Weight (kg) 19.2 (4.5) 17.3 (3.7) .038 
BMI (kg/m213.6 (1.5) 13.0 (1.6) .070 
Height-for-age z score −1.5 (1.3) −1.8 (1.2) .186 
Weight-for-age z score −2.1 (1.1) −2.6 (1.2) .016 
BMI z score −1.9 (1.3) −2.2 (1.6) .161 
Characteristics Survived (n = 407)Died (n = 24)P value 
Age at enrollment, median (IQR) 7.7 (6.0-10.1) 7.5 (6.3-9.0) .778 
Female 211 (51.8) 13 (54.2) .825 
Total hemoglobin (g/dL), median (IQR) 7.3 (6.7-8.1) 7.2 (6.4-7.2) .547 
White blood cell count (103/mm3), median (IQR) 13.5 (11.2-16.9) 14.1 (12.5-17.3) .580 
Transcranial Doppler velocity at screening (cm/s), median (IQR) 200.0 (130.0-206.0) 203.5 (146.3-219.0) .113 
Height (cm) 118.5 (11.8) 115.1 (10.9) .168 
Weight (kg) 19.2 (4.5) 17.3 (3.7) .038 
BMI (kg/m213.6 (1.5) 13.0 (1.6) .070 
Height-for-age z score −1.5 (1.3) −1.8 (1.2) .186 
Weight-for-age z score −2.1 (1.1) −2.6 (1.2) .016 
BMI z score −1.9 (1.3) −2.2 (1.6) .161 

IQR, interquartile range; SD, standard deviation.

The therapy group comprised of children with abnormal transcranial Doppler velocities on hydroxyurea therapy, and the comparison group was children with nonelevated transcranial Doppler velocities.

Mean (SD) for continuous variables and counts (percentages) for categorical variables, unless otherwise noted.

χ2 test for counts, t test for means, Mann-Whitney U test for medians.

Close Modal

or Create an Account

Close Modal
Close Modal